Ezetimibe Medications
Ezetimibe is a lipid-lowering compound that inhibits cholesterol absorption in the small intestine, used to treat hypercholesterolemia.
Ezetimibe Information
Ezetimibe is a cholesterol-lowering agent that works by blocking the intestinal absorption of both dietary and biliary cholesterol. Classified as a selective cholesterol-absorption inhibitor, it is commonly prescribed for patients with primary hypercholesterolemia, heterozygous familial hypercholesterolemia, and as an adjunct to statin therapy when LDL-C goals remain unmet. Branded products such as Zetia and Lipten are widely available, while generic versions are listed in most pharmacopeias. In Singapore, the Health Sciences Authority (HSA) has approved ezetimibe as a monotherapy and in fixed-dose combinations with statins, reflecting its established role in lipid management. Although primarily indicated for cholesterol reduction, clinicians occasionally use ezetimibe for rare conditions like sitosterolemia, where it effectively lowers plant sterol levels. Its safety profile, dosing flexibility, and compatibility with other lipid-lowering drugs make it a valuable option for adults seeking to control cardiovascular risk.
What is ezetimibe?
Ezetimibe belongs to the class of selective cholesterol-absorption inhibitors. The HSA first approved ezetimibe in 2006 for the treatment of hypercholesterolemia, and the FDA and EMA subsequently endorsed the same indication, expanding its use to include homozygous familial hypercholesterolemia when combined with statins. The drug targets the Niemann-Pick C1-like 1 (NPC1L1) transporter located on the brush-border of enterocytes, thereby reducing the intestinal uptake of cholesterol. By limiting the influx of cholesterol into the bloodstream, ezetimibe lowers low-density lipoprotein cholesterol (LDL-C) without directly affecting hepatic cholesterol synthesis. Both branded medicines (e.g., Zetia, Lipten) and generic formulations are stocked in our online pharmacy, allowing convenient access for Singaporean patients.
How ezetimibe works
Mechanism of Action
Ezetimibe binds to the NPC1L1 protein on the apical surface of intestinal cells, inhibiting the transporter’s ability to incorporate cholesterol into the micelle phase. This blockade prevents roughly 50 % of dietary and biliary cholesterol from entering the enterohepatic circulation.
Therapeutic Effects
Reduced intestinal cholesterol absorption leads to a downstream decrease in hepatic cholesterol pools. The liver responds by up-regulating the expression of LDL receptors, enhancing clearance of circulating LDL particles. Clinically, this translates into a 15-20 % reduction in LDL-C when ezetimibe is used alone, and up to an additional 15 % when combined with a statin.
Onset and Duration
Peak plasma concentrations are reached within 4-6 hours after oral administration, and steady-state levels are achieved after five days of daily dosing. The LDL-C-lowering effect persists for the dosing interval, making once-daily administration sufficient for most patients.
Approved uses and applications
Approved indications
- Primary hypercholesterolemia in adults (HSA, FDA).
- Heterozygous familial hypercholesterolemia (EMA).
- Adjunct to statin therapy for patients who fail to meet LDL-C targets (HSA).
- Sitosterolemia, a rare disorder of plant-sterol accumulation (FDA).
Off-label uses
Ezetimibe has been explored off-label for reducing cholesterol absorption in liver-transplant recipients and for adjunctive therapy in non-alcoholic fatty liver disease. These applications are not officially sanctioned by regulatory agencies, and clinicians must weigh the limited evidence before prescribing.
Clinical efficacy
In the SHARP trial, ezetimibe added to simvastatin produced a 17 % further reduction in LDL-C compared with simvastatin alone, and a meta-analysis published in The Lancet reported a relative risk reduction of 10 % for major cardiovascular events when ezetimibe is combined with statins.
Buying ezetimibe from our online pharmacy
Why choose our service
Our online pharmacy offers a discreet, secure platform that bridges gaps in medication availability, especially for patients who encounter stock shortages in local outlets. By sourcing from licensed international pharmacies, we ensure product authenticity while maintaining competitive pricing.
Brand names and generic options
- Zetia 10 mg tablets (brand).
- Lipten 10 mg tablets (brand).
- Ezetimibe 10 mg generic (cost-effective).
Quality & safety
All suppliers are vetted under WHO-Good Manufacturing Practice standards and operate under the oversight of regulatory bodies such as the HSA. This guarantees that each batch meets stringent purity and potency criteria.
Pricing & access
Generic ezetimibe is typically 30-40 % cheaper than branded equivalents. Customers benefit from a lifetime 10 % discount on all reorders, making long-term therapy more affordable.
Discreet delivery
Orders shipped via our service arrive in protective, unmarked packaging. Express delivery reaches most Singapore addresses within ≈ 7 days, while standard shipping completes within ≈ 3 weeks.
Dosing, formulations & administration
Available formulations
Ezetimibe is marketed as 10 mg oral tablets, both as monotherapy and in fixed-dose combinations (e.g., ezetimibe 10 mg/simvastatin 20 mg).
Typical dosing ranges
For adults with primary hypercholesterolemia, clinicians often start ezetimibe at 10 mg once daily. In combination therapy, the same dose is paired with a statin, and adjustments are made based on LDL-C response and tolerability. Dose escalation beyond 10 mg is not recommended.
Administration guidelines
Ezetimibe can be taken with or without food; however, taking the tablet at the same time each day improves adherence. Patients should avoid grapefruit juice when using ezetimibe-statin combinations, as it may affect statin metabolism.
The exact dose and regimen must be determined by a qualified healthcare provider after evaluating individual risk factors and concurrent medications.
Safety profile & considerations
Common side effects
- Abdominal discomfort (≈ 12 % of users).
- Diarrhoea (≈ 8 %).
- Fatigue (≈ 7 %).
- Myalgia (≈ 5 %).
- Elevated transaminases (≈ 3 %).
These events are generally mild and transient.
Serious adverse events
Rare cases of hepatitis, gallstone formation, and severe myopathy have been reported, especially when ezetimibe is combined with high-intensity statins. Immediate medical evaluation is warranted if muscle pain is accompanied by dark urine or marked CK elevation.
Contraindications
- Active liver disease or unexplained persistent elevations of hepatic enzymes.
- Pregnancy and lactation (insufficient safety data).
- Known hypersensitivity to ezetimibe or any excipients.
Drug interactions
- CYP3A4 inhibitors (e.g., ketoconazole) may increase systemic exposure to co-formulated statins.
- Cyclosporine raises ezetimibe plasma levels; dose adjustment is advised.
- Other lipid-lowering agents (e.g., fibrates) increase the risk of myopathy.
Special populations
- Pregnancy & breastfeeding: Use only if potential benefit outweighs risk.
- Elderly: No dose modification required, but monitor hepatic function.
- Renal or hepatic impairment: No dosage change is needed, yet regular lab assessments are recommended.
Frequently asked questions
-
How does ezetimibe differ from a statin? Ezetimibe blocks cholesterol absorption in the gut, whereas statins inhibit hepatic cholesterol synthesis. The two mechanisms are complementary, allowing combined use for greater LDL-C reduction.
-
How long before ezetimibe produces noticeable effects for high cholesterol? LDL-C reductions are observable within 2-4 weeks of daily therapy, with maximal effect typically reached after about 6 weeks.
-
What should I do if I experience abdominal pain after taking ezetimibe? Mild discomfort often resolves spontaneously; however, persistent or severe pain should prompt a consultation to rule out gastrointestinal complications.
-
Can ezetimibe cause muscle aches when used with a statin? Yes, the combination can increase the risk of myopathy. Report any unexplained muscle weakness, tenderness, or dark urine to a healthcare professional promptly.
-
Does taking ezetimibe with food affect its absorption? Food does not significantly alter ezetimibe bioavailability, so the tablet may be taken with or without meals.
-
Are there any foods I should avoid while on ezetimibe? No specific dietary restrictions are required, but patients on combination therapy should limit grapefruit juice, which can elevate statin levels.
-
Is ezetimibe safe for long-term use? Long-term studies spanning up to 5 years have shown sustained LDL-C lowering without a rise in serious adverse events, provided liver function is monitored regularly.
-
Can ezetimibe be used in patients with sitosterolemia? Yes, ezetimibe effectively reduces plant sterol concentrations and is recommended as first-line therapy for this rare disorder.
-
What information should I provide my doctor when discussing ezetimibe?
- Complete list of current medications, including over-the-counter drugs and supplements.
- History of liver disease, muscle disorders, or gallstones.
- Recent lipid panel results and cardiovascular risk factors.
- Any previous adverse reactions to cholesterol-lowering agents.
Disclaimer
The information provided about ezetimibe is for general knowledge only. It does not replace professional medical consultation or the official prescribing information for medications containing this ingredient. All treatment decisions, including dosing, formulation selection, and monitoring, should be made under the supervision of a qualified healthcare provider who can assess individual medical history, current medications, and specific health needs. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to medications containing ezetimibe for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication containing ezetimibe.